Total of 676 Biotech and Pharma Takeovers in the Past 3 Years — M&A Activity Expected to Rise in 2013

Five Star Equities Provides Stock Research on Anacor Pharmaceuticals and Spectrum Pharmaceuticals

Continue Reading

U.S. Refiners Soar in 2012 as Increased Access to North American Crude Improves Margins

Research Driven Investing Provides Stocks Research on Valero Energy and Tesoro

Continue Reading

Canadian Banks Receive Credit Rating Downgrades From Moody-s

Research Driven Investing Provides Stocks Research on CIBC and TD Bank

Continue Reading

Recoveries in U.S. Housing and Automotive Markets Help Offset Drops in Coal Demand for Railroad Companies

Five Star Equities Provides Stock Research on Norfolk Southern and Union Pacific

Continue Reading

Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost Revenues

Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Repros Therapeutics

Continue Reading

Six Canadian Banks Ratings Downgraded — Canadian Consumer Debt at a Record High

Research Driven Investing Provides Stocks Research on Bank of Nova Scotia and Royal Bank of Canada

Continue Reading

Despite Facing Steep Drops in Coal Shipments Railroads Posting Strong Earnings

Five Star Equities Provides Stock Research on CSX and Kansas City Southern

Continue Reading

Biotech Industry Expected to Experience More Merger & Acquisition Activity in 2013

Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and Vical

Continue Reading

U.S. Health Care Spending Projected to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on UnitedHealth Group and WellCare

Continue Reading

Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on Health Care REIT and Health Management Associates

Continue Reading